DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR). - Shah, Neil P.; García-Gutiérrez, J. Valentín; Jiménez-Velasco, Antonio; Larson, Sarah; Saussele, Susanne; Rea, Delphine; Mahon, François-Xavier; Levy, Moshe Yair; Gómez-Casares, María Teresa; Luciano, Luigia; Nicolini, Franck-Emmanuel; Mauro, Michael J.; et al. (Clinical lymphoma, myeloma & leukemia, 2019)